Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has adopted the amended 'Code of Conduct to Regulate, Monitor and Report Trading in Securities' and 'Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information' in Compliance with SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018. The above code is also being uploaded on the website of the company w.e.f 01st April, 2019. This is for your information and records
30-03-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Kishoriju Trading And Investment Pvt Ltd
28-02-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SICOM Ltd
22-02-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Radhika A Dhoot
18-02-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SICOM Ltd
15-02-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Smita A Dhoot
15-02-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Clarification

With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Mangalam Drugs & Organics Ltd has submitted to BSE a copy of Clarification is enclosed.
15-02-2019
Bigul

Mangalam Drugs & Organics Ltd - 532637 - Clarification Sought on Price Movement

The Exchange has sought clarification from Mangalam Drugs & Organics Ltd on February 14, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.
14-02-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raj Exports Pvt Ltd
14-02-2019
Bigul

MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication

In compliance of provisions of Regulation 47 of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to enclose copies each of Free Press Journal(English Daily) and Navshakti(Marathi Daily) both dated 12th February, 2019 in which un-audited financial results of the company for the quarter ended 31st December, 2018, have been published. The aforesaid results have been approved by the Board of Directors in its meeting held on 11th February, 2019.
12-02-2019
Next Page
Close

Let's Open Free Demat Account